Global Continuous Glucose Monitoring (CGM) Sensors Market Size is valued at USD 7.6 Billion in 2024 and is predicted to reach USD 19.9 Billion by the year 2034 at a 10.2% CAGR during the forecast period for 2025-2034.
Diabetes technology has progressed remarkably over the past few years, including the development of markers for diabetes control, sophisticated monitoring techniques, mathematical models, assessment procedures, and control algorithms. Continuous glucose monitoring (CGM) sensors provide an effective approach in diabetes management as it checks glucose levels in real-time, displays the change in glucose levels. It also can be used as a tool to predict impending glucose excursions and to assess glycaemic variability. The clinical use of CGM also lowers the risk of mild to moderate hypoglycemia and eradicates the risk of severe and prolonged hypoglycemia.
These devices can be segregated as totally invasive, minimally invasive, and noninvasive based on the nature of their operation. Currently, automation of glucose monitoring is anticipated to save significant nursing time while improving glucose control and safety. The Global Continuous Glucose Monitoring (CGM) Sensors market is expected to be driven mainly by the growing prevalence of Type 1 and Type 2 diabetes along with the growing geriatric population over the forecast period.
Furthermore, rapidly shifting consumer predilections toward an effective approach to manage diabetes, robust adoption of advanced diabetes management solutions in developing regions, favorable government policies, and rising healthcare spending over time across the globe, growing health awareness, increasing medical tourism, and easy affordability are key factors that are projected to further aid the market growth during the forecast period.
The Global Continuous Glucose Monitoring (CGM) Sensors Market is categorized on the basis of products, sensing technology, end-users, patient population, sites, and region.
Market Segmentation
Continuous Glucose Monitoring (CGM) Sensors Market is segmented into sensor type/technology, wear time, application and end-user. By Sensor Type/Technology segment, the market is segmented into Real-Time CGM Sensors, Intermittently Scanned CGM Sensors (Flash), Implantable CGM Sensors, Non-Invasive CGM Sensors. As per the application segment, the market is classified into Home Care/Personal Use, Hospitals & Clinics, Others). By Wear Time the makret is divided into Short-Term Sensors (7-14 days), Long-Term Sensors (180-365 days), Daily Sensors (1-day). By End-User segment is segmented into Consumers (Home Use), Athletes/Fitness Enthusiasts (Elderly Population, Healthcare Providers). Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.
Competitive Landscape
Some Of The Key Players In The Continuous Glucose Monitoring (CGM) Sensors Market:
- Medtronics,
- Dexcom,
- Senseonics,
- WaveForm Technologies, Inc.,
- Abbott Diabetes Care Inc,
- Arkal Medical, Inc.,
- Ascensia Diabetes Care Holdings AG,
- Biorasis Inc,
- Debiotech SA,
- DirectSens GmbH,
- Echo Therapeutics Inc,
- EyeSense GmbH,
- Flowsion A/S,
- GlucoSet AS,
- Glucovation Inc,
- Glusense Ltd,
- GlySens Inc,
- iGlyko, Inc.,
- Indigo Diabetes NV,
- Insulet Corp,
- Integrated Medical Sensors,
- Integrity Applications Ltd,
- I-Sens Inc,
- Metronom Health Inc,
- Nemaura Medical Inc,
- PKvitality,
- Prediktor Medical AS,
- Profusa Inc,
- San Meditech (Huzhou) Co., Ltd.,
- Senzime AB,
- Socrates Health Solutions, Inc.,
- Other prominent players
The Continuous Glucose Monitoring (CGM) Sensors Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2024 |
USD 7.6 Billion |
Revenue Forecast In 2034 |
USD 19.9 Billion |
Growth Rate CAGR |
CAGR of 10.2% from 2025 to 2034 |
Quantitative Units |
Representation of revenue in US$ Bn,and CAGR from 2025 to 2034 |
Historic Year |
2021 to 2024 |
Forecast Year |
2025-2034 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Sensor Type/Technology, By End-Users, By Wear Time, By Application |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia; |
Competitive Landscape |
Medtronics, Dexcom, Senseonics, WaveForm Technologies, Inc., Abbott Diabetes Care Inc, Arkal Medical, Inc., Ascensia Diabetes Care Holdings AG, Biorasis Inc, Debiotech SA, DirectSens GmbH, Echo Therapeutics Inc, EyeSense GmbH, Flowsion A/S, GlucoSet AS, Glucovation Inc, Glusense Ltd, GlySens Inc, iGlyko, Inc., Indigo Diabetes NV, Insulet Corp, Integrated Medical Sensors, Integrity Applications Ltd, I-Sens Inc, Metronom Health Inc, Nemaura Medical Inc, PKvitality, Prediktor Medical AS, Profusa Inc, San Meditech (Huzhou) Co., Ltd., Senzime AB, Socrates Health Solutions, Inc., and other prominent players. |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |